Gene-behavior interaction of depressive symptoms and the apolipoprotein e ε4 allele on cognitive decline

Psychosomatic Medicine

Volumn 76, Issue 2, 2014, Pages 101-108

  Rajan, Kumar B ^a   Wilson, Robert S ^b,c   Skarupski, Kimberly A ^d   Mendes De Leon, Carlos F ^e   Evans, Denis A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

APOE gene; cognitive decline; depressive symptoms; gene behavior interaction

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ARTICLE; COGNITIVE DEFECT; DEPRESSION; DNA DETERMINATION; FEMALE; GENETIC LINKAGE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

APOE GENE; COGNITIVE DECLINE; DEPRESSIVE SYMPTOMS; GENE-BEHAVIOR INTERACTION;

AFRICAN AMERICANS; AGED; ALLELES; APOLIPOPROTEIN E4; COGNITION DISORDERS; DEPRESSION; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; GERIATRIC ASSESSMENT; HUMANS; INTELLIGENCE TESTS; INTERVIEW, PSYCHOLOGICAL; LIFE STYLE; LINEAR MODELS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; TIME FACTORS;

EID: 84894461440     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000029     Document Type: Article

References (47)

1. HeW, Sengupta M, Velkoff VA, DeBarros KA. U.S. Census Bureau, Current Population Reports, P23-209, 65+ in the United States. Washington, DC: U.S. Government Printing Office. 2005:23-209.
2. Djernes JK. Prevalence and predictors of depression in populations of elderly: a review. Acta Psychiatr Scand 2006;113:372-87.
3. Beekman AT, Copeland JR, Prince MJ. Review of community prevalence of depression in later life. Br J Psychiatry 1999;174:307-11.
4. Cole MG, Bellavance F, Mansour A. Prognosis of depression in elderly community and primary care populations: a systematic review and metaanalysis. Am J Psychiatry 1999;156:1182-89.
5. Mills TL. Comorbid depressive symptomatology: isolating the effects of chronic medical conditions on self-reported depressive symptoms among community-dwelling older adults. Soc Sci Med 2001;53:569-78.
6. Skarupski KA, Mendes de Leon CF, Bienias JL, Barnes LL, Everson-Rose SA, Wilson RS, Evans DA. Black-white differences in depressive symptoms among older adults over time. J Gerontol B Psychol Sci Soc Sci 2005;60:136-42.
7. Harris T, Cook D, Victor C, DeWilde S, Beighton C. Onset and persistence of depression in older peopleVresults from a 2-year community follow-up study. Age Ageing 2006;35:25-32.
8. Everson-Rose SA, Skarupski KA, Bienias JL, Wilson RS, Evans DA, Mendes de Leon CF. Do depressive symptoms predict declines in physical performance in an elderly, biracial population? Psychosom Med 2005;67: 609-15.
9. Whooley MA, Browner WS. Association between depressive symptoms and mortality in older women. Study of osteoporotic fractures research group. Arch Intern Med 1998;158:2129-35.
10. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006;63:530-8.
11. Gao Y, Huang C, Zhao K, Ma L, Qiu X, Zhang L, Xiu Y, Chen L, Lu W, Huang C, Tang Y, Xiao Q. Depression as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Int J Geriatr Psychiatry 2013;28:441-9.
12. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry 2013;202:329-35.
13. Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, Schneider JS, Bach J, Pilat J, Beckett LA, Arnold SE, Evans DA, Bennett DA. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002;59:364-70.
14. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Altered gene expression of brain derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003;60:804-15.
15. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, Duara R, Kukull WA, Chui H, Edeki T, Griffith PA, Friedland RP, Bachman D, Farrer L. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol 2003;60:753-9.
16. Meeks TW, Ropacki SA, Jeste DV. The neurobiology of neuropsychiatric syndromes in dementia. Curr Opin Psychiatry 2006;19:581-6.
17. Yen YC, Rebok GW, Gallo JJ, Yang MJ, Lung FW, Shih CH. ApoE4 allele is associated with late-life depression: a population-based study. Am J Geriatr Psychiatry 2007;15:858-68.
18. Rigaud AS, Traykov L, Caputo L, Coste J, Latour F, Couderc R, Moulin F, Boller F, Forette F. Association of the apolipoprotein E-e4 allele with lateonset depression. Neuroepidemiology 2001;20:268-72.
19. Kessing LV, Jorgensen OS. Apolipoprotein E-e4 frequency in affective disorder. Biol Psychiatry 1999;45:430-4, 22.
20. Cervilla J, Prince M, Joels S, Russ C, Levestone S. Genes related to vascular disease (APOE, VLDL-R, DCP-1) and other vascular factors in latelife depression. Am J Geriatr Psychiatry 2004;12:202-10.
21. Niti M, Yap KB, Kua EH, Ng TP. APOE D4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore longitudinal studies. J Gerontol A Biol Sci Med Sci 2009;64:306-11.
22. Dean K, Oulhaj A, Zamboni G, deJager CA, Wilcock GK. Role of depression in predicting time to conversion to mild cognitive impairment. Am J Geriatr Psychiatry. 2013;pii:S1064-7481(12)00135-2.
23. Geda YE, Knopman DS, Mrazek DA, Jicha GA, Smith GE, Negash S, Boeve BF, Ivnik RJ, Petersen RC, Pankratz VS, Rocca WA. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol 2006;63:435.
24. Irie F, Masaki KH, Petrovitch H, Abbott RD, Ross GW, Taaffe DR, Launer LJ, White LR. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study. Arch Gen Psychiatry 2008;65:906-12. 23.
25. Corsentino EA, Sawyer K, Sachs-Ericsson N, Blazer DG. Depressive symptoms moderate the influence of the apolipoprotein E-epsilon4 allele on cognitive decline in a sample of community dwelling older adults. Am J Geriatr Psychiatry 2009;17:155-65.
26. Freiheit EA, Hogan DB, Eliasziw M, Patten SB, Demchuk AM, Faris P, Anderson T, GalbraithD, Parboosingh JS,GhaliWA,KnudtsonM,Maxwell CJ.A dynamic view of depressive symptoms and neurocognitive change among patients with coronary artery disease. Arch Gen Psychiatry 2012;69:244-55. 27.
27. Evans DA, Bennett DA,Wilson RS, Bienias JL, Morris MC, Scherr PA, Hebert LE,AggarwalN, Beckett LA, Joglekar R, Berry-Kravis E, Schneider J. Incidence ofAlzheimer disease in a biracial urban community.ArchNeurol 2003;60:185-9.
28. Bienias JL, Beckett LA, Bennett DA,Wilson RS, Evans DA. Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis 2003;5: 349-55.
29. Albert M, Smith LA, Scherr PA, Taylor JO, Evans DA, Funkenstein HH. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 1991;57:167-78.
30. Wilson RS, Bennett DA, Bienias JL, Aggarwal NT, Mendes De Leon CF, Morris MC, Schneider JA, Evans DA. Cognitive activity and incident AD in a population-based sample of older adults. Neurology 2002;59:1910-4.
31. Smith A. Symbol Digits Modalities Test. Los Angeles: Western Psychological Services; 1982.
32. Folstein MF, Folstein SE, McHugh TR. "Mini-Mental Staté'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
33. Wilson RS, Bennett DA, Beckett LA, Morris MC, Gilley DW, Bienias JL, Scherr PA, Evans DA. Cognitive activity in older persons from a geographically defined population. J Gerontol B Psychol Sci Soc Sci 1999;54: 155-60.
34. Kohout FJ, Berkman LF, Evans DA, Cornoni-Huntley J. Two shorter forms of the CES-D depression symptoms index. J Aging Health 1993;5:179-93.
35. Shafer AB. Meta-analysis of the factor structures of 4 depression questionnaires: Beck, CES-D, Hamilton, and Zung. J Clin Psychol 2006;62: 123-46.
36. Wilson RS, Hoganson GM, Rajan KB, Barnes LL, Mendes de Leon CF, Evans DA. Temporal course of depressive symptoms during the development of Alzheimer disease. Neurology 2010;75:21-6.
37. Wilson RS, Nag S, Boyle PA, Hizel LP, Yu L, Buchman AS, Shah RC, Schneider JA, Arnold SE, Bennett DA. Brainstem aminergic nuclei and late life depressive symptoms. JAMA Psychiatry. In press.
38. Hixson J, Vernier DO. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hha l. J Lipid Res 1990;31:545-48.
39. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by onestage PCR. Lancet 1991;337:1158-59.
40. Packard CJ,Westendorp RG, Stott DJ, Caslake MJ, Murray HM, Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Jolles J, Perry IJ, Sweeney BJ, Twomey C; Prospective Study of Pravastatin in the Elderly at Risk Group. Association between apolipoprotein E4 and cognitive decline in elderly adults. J Am Geriatr Soc 2007;55:1777-85.
41. Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE. The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging. Neurology 2003;60:1077-81.
42. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease. JAMA 1997;278:1349-56.
43. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
44. Canty AJ, Davison AC. Resampling-based variance estimation for labor force surveys. The Statistician 1999;48:379-91.
45. Preston J. Rescaled bootstrap for stratified multistage sampling. Survey Methodology 2009;35:227-34.
46. Core Team R. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2012.
47. Ward A, Crean S, Mercaldi CJ, Collins JM, Boyd D, Cook MN, Arrighi HM. Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis. Neuroepidemiology 2012;38:1-17.